Q2 2026 Holdings
Filed 2026-07-09 | 75 holdings | $187.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI) | ST STR SP BIOT | 78464A870 | $90.2M | 570,000 | 48.0% |
| Ishares TR(SGOV) | 0-3 MTH TREASURY | 46436E718 | $70.5M | 700,000 | 37.5% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $616.8K | 11,000 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $606.5K | 25,000 | 0.3% |
| Incyte Corp(INCY) | COM | 45337C102 | $600.8K | 5,300 | 0.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $594.7K | 641 | 0.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $585.1K | 8,000 | 0.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $583.4K | 14,000 | 0.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $567.6K | 17,000 | 0.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $559.5K | 30,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $556.6K | 23,000 | 0.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $549.4K | 10,000 | 0.3% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $547.9K | 7,000 | 0.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $539.2K | 6,800 | 0.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $518.7K | 15,000 | 0.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $516.5K | 19,700 | 0.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $509.1K | 30,000 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $505.6K | 3,000 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $500.9K | 13,000 | 0.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $500.1K | 19,766 | 0.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $489.4K | 6,000 | 0.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $483.7K | 13,000 | 0.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $480.7K | 15,141 | 0.3% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $470.4K | 10,000 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $464.4K | 12,000 | 0.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $458.7K | 4,000 | 0.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $444.2K | 20,000 | 0.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $441.0K | 1,465 | 0.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $440.6K | 7,000 | 0.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $437.2K | 20,000 | 0.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $435.3K | 8,000 | 0.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $411.6K | 11,000 | 0.2% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $406.7K | 12,000 | 0.2% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $400.1K | 1,500 | 0.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $398.7K | 5,000 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $392.6K | 12,000 | 0.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $390.1K | 10,000 | 0.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $381.4K | 18,000 | 0.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $367.7K | 3,000 | 0.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $364.1K | 10,000 | 0.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $355.3K | 7,000 | 0.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $355.1K | 4,000 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $338.4K | 20,000 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $322.2K | 600 | 0.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $319.8K | 5,000 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $314.4K | 6,000 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $312.6K | 10,000 | 0.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $306.0K | 60,000 | 0.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $300.4K | 7,000 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $292.7K | 2,500 | 0.2% |